TSX News -
Bombardier Announces April 3, 2024 as the Start of its New Normal Course Issuer Bid
MONTRÉAL, April 01, 2024 (GLOBE NEWSWIRE) — Bombardier Inc. (TSX: BBD.B) (“Bombardier” or the “Corporation”) confirmed today that its new […]
TSX News -
Discovery Files NI 43-101 Technical Report for the Cordero Project Feasibility Study
TORONTO, April 01, 2024 (GLOBE NEWSWIRE) — Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced […]
Vital Energy Announces Offering of $100.0 Million of Senior Notes
TULSA, OK, April 01, 2024 (GLOBE NEWSWIRE) — Vital Energy, Inc., a Delaware corporation (NYSE: VTLE) (“Vital Energy” or the […]
Rakovina Therapeutics To Host Informational Webinar on April 3, 2024
VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV), (“Rakovina Therapeutics” or the “Company”), a […]
TSX News -
Bitfarms Announces March 2024 Production and Operations Update
– Company earns 286 BTC in March 2024 – – Upgrade and expansion plan, targeting 21 EH/s and 21w/TH in […]
TSX News -
Enthusiast Gaming Advances Strategic Objectives with C$4.1 Million Sale of Select Non-Core Assets
LOS ANGELES, April 01, 2024 (GLOBE NEWSWIRE) — Enthusiast Gaming Holdings Inc. (“Enthusiast Gaming” or the “Company”) (TSX: EGLX), a […]
TSX News -
Telesat and Government of Canada Agree to Terms on C$2.14 Billion Loan in Support of Telesat Lightspeed
OTTAWA, April 01, 2024 (GLOBE NEWSWIRE) — Telesat (NASDAQ and TSX: TSAT), one of the world’s largest and most innovative […]
Xtant Medical Announces Record Full Year 2023 Revenue of $91.3 Million
Establishes Full Year 2024 Revenue Guidance of $112 Million – $116 Million BELGRADE, Mont., April 01, 2024 (GLOBE NEWSWIRE) — […]
Sachem Capital Reports Full Year 2023 Results
Revenues Increase, While Rising Interest Rates and Commercial Real Estate Values Impact Earnings Company to Host Webcast and Conference Call […]
Algernon Pharmaceuticals to Move Forward with Psychedelic Drug DMT Stroke Research Program as its Lead Asset
VANCOUVER, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (the “Company” or “Algernon”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: […]
